7 reports of this reaction
6.9% of all INFANTS IBUPROFEN reports
#2 most reported adverse reaction
VOMITING is the #2 most commonly reported adverse reaction for INFANTS IBUPROFEN, manufactured by Aurohealth LLC. There are 7 FDA adverse event reports linking INFANTS IBUPROFEN to VOMITING. This represents approximately 6.9% of all 101 adverse event reports for this drug.
Patients taking INFANTS IBUPROFEN who experience vomiting should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
VOMITING is moderately reported among INFANTS IBUPROFEN users, representing a notable but not dominant share of adverse events.
In addition to vomiting, the following adverse reactions have been reported for INFANTS IBUPROFEN:
The following drugs have also been linked to vomiting in FDA adverse event reports:
VOMITING has been reported as an adverse event in 7 FDA reports for INFANTS IBUPROFEN. This does not prove causation, but indicates an association observed in post-market surveillance data.
VOMITING accounts for approximately 6.9% of all adverse event reports for INFANTS IBUPROFEN, making it one of the most commonly reported side effect.
If you experience vomiting while taking INFANTS IBUPROFEN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.